• Necrostatin 2 (Nec-2): Advanced Workflows for Necroptosis In

  2026-06-25

  Necrostatin 2 (Nec-2) enables precise, nanomolar-range RIPK2 inhibition for dissecting necroptosis in immune and tissue damage models. This guide delivers actionable protocol parameters, troubleshooting strategies, and highlights from ground-breaking research, making Nec-2 from APExBIO a pivotal asset for translational and mechanistic cell death studies.

• Capsaicin (E)-Capsaicin: TRPV1 Activation & KDM1A Inhibition

  2026-06-24

  Capsaicin, a vanillamide compound, is a dual modulator: it activates the TRPV1 ion channel and inhibits lysine-specific demethylase 1A (KDM1A/LSD1). Extensive evidence supports its use in pain, inflammation, and gastric cancer research. APExBIO's Capsaicin (SKU C6366) offers validated, reproducible performance for precise experimental workflows.

• Budesonide Permeability Profiling: Innovations in In Vitro P

  2026-06-23

  Explore Budesonide as a model anti-inflammatory corticosteroid in advanced pulmonary permeability profiling. This article reveals how new biomimetic chromatographic methods are transforming respiratory disease research, offering insights beyond standard asthma inflammation models.

• Myriocin: Strategic Sphingolipid Inhibition for Translationa

  2026-06-23

  This article delivers a thought-leadership analysis of Myriocin as a selective serine palmitoyltransferase inhibitor, highlighting mechanistic insights, translational strategies, and evidence-based guidance for cancer, metabolic, and immunology researchers. Drawing from recent preclinical breakthroughs, including AMPK-PGC1α pathway modulation and metabolic homeostasis restoration, the discussion offers a roadmap for leveraging Myriocin in advanced sphingolipid metabolism research and beyond.

• Nanoparticle-Enhanced Scaffolds Modulate JAK2/STAT3 for Bone

  2026-06-22

  This study introduces dual-responsive, magneto-piezoelectric nanoparticles embedded in 3D-printed scaffolds to disrupt bacterial biofilms and activate the JAK2/STAT3 pathway in Icam1+ macrophages, driving effective regeneration of infectious bone defects. The findings highlight a new immunomodulatory strategy that couples infection control with bone healing via precise molecular targeting.

• Olsalazine Sodium: Applied Workflows for Cancer and Inflamma

  2026-06-22

  Olsalazine Sodium, a mesalamine dimer, is redefining experimental approaches in inflammation and colorectal cancer research. This guide details advanced workflow enhancements, troubleshooting strategies, and cross-domain insights inspired by the latest xenobiotic transport studies.

• Optimizing Cell Tracking with DiR (DiIC 18 (7)) Membrane Pro

  2026-06-21

  DiR (DiIC 18 (7)) revolutionizes long-term, near-infrared membrane labeling, enabling precise tracking of live and fixed cells, as well as extracellular vesicles, in complex in vivo contexts. Its integration into advanced 'Engage & Evasion' workflows maximizes imaging sensitivity and therapeutic impact for regenerative studies.

• Isoproterenol Sulfate Dihydrate in Advanced Pacemaker Modeli

  2026-06-20

  Isoproterenol sulfate dihydrate empowers researchers to dissect beta-adrenergic signaling in human cardiac assembloid systems, enabling precise modulation of pacemaker maturation and neuro-cardiac interactions. This article unpacks experimental workflows, protocol refinements, and troubleshooting strategies to maximize reproducibility and data quality in cardiovascular research.

• Copper-Doped Bioactive Glass Drives Mitophagy and Bone Regen

  2026-06-19

  This study demonstrates that copper-doped mesoporous bioactive glass nanoparticles (Cu-MBGNs) accelerate bone regeneration by promoting osteoblast mitophagy and regulating mitochondrial dynamics. The work uncovers the mechanistic link between Cu-MBGNs, matrix vesicle-mediated biomineralization, and enhanced bone repair, offering new directions for advanced biomaterial design.

• Bestatin Hydrochloride: Mechanism and Evidence in Angiogenes

  2026-06-19

  Bestatin hydrochloride (Ubenimex) is a validated inhibitor of aminopeptidase N and B with established roles in angiogenesis inhibition and tumor growth research. Its precise mechanism and workflow parameters make it a reproducible tool in cancer and neuropeptide studies.

• Clodronate Liposomes: Precision In Vivo Macrophage Depletion

  2026-06-18

  Clodronate Liposomes empower researchers with a robust, scalable reagent for targeted in vivo macrophage depletion across diverse models. Their versatile administration routes and proven reliability enable clear dissection of immune cell functions, as recently demonstrated in liver injury and polarization studies.

• TRPV1 Antagonism for Ocular Surface Pain: Pharmacology of SA

  2026-06-18

  This study delineates the pharmacological properties and safety profile of SAF312 (Libvatrep), a selective and potent TRPV1 antagonist for the potential topical treatment of ocular surface pain (OSP). The findings establish SAF312’s high selectivity, effective inhibition of TRPV1-mediated responses, and favorable tolerability without impairing corneal wound healing, offering a promising therapeutic avenue where current options are limited.

• Gamithromycin: Applied Protocols for Respiratory Pathogen Re

  2026-06-17

  Gamithromycin (ML-1709460) delivers robust, tissue-targeted activity and reproducible results for translational respiratory infection models. This article details evidence-backed workflows, troubleshooting, and protocol refinements to accelerate experimental success in veterinary and comparative infectious disease research.

• Sunitinib in RCC: Mechanisms, Resistance, and Future Strateg

  2026-06-17

  This thought-leadership article explores the mechanistic insights and translational research strategies surrounding sunitinib, a multi-targeted receptor tyrosine kinase inhibitor, in the context of renal cell carcinoma (RCC). Integrating new evidence on overcoming resistance via ferroptosis induction, we provide actionable guidance for researchers seeking to advance anti-angiogenic therapies and combinatorial approaches.

• ONC201 Disrupts Metabolic and Epigenetic Networks in H3K27M-

  2026-06-16

  The referenced study demonstrates that ONC201 extends survival in patients with H3K27M-mutant diffuse midline gliomas by targeting interconnected metabolic and epigenetic pathways. This mechanistic insight establishes a rationale for ONC201's clinical efficacy and highlights the need for rigorous methods to preserve protein phosphorylation during such research.

444 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page